Role of the GMP facility for adoptive immunotherapy
Cytotherapy
.
2002;4(4):329-31.
doi: 10.1080/146532402760271109.
Authors
J D McMannis
1
,
R E Champlin
Affiliation
1
Department of Blood and Marrow Transplantation, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
PMID:
12396832
DOI:
10.1080/146532402760271109
No abstract available
MeSH terms
Accreditation*
Clinical Laboratory Techniques* / standards
Guidelines as Topic
Humans
Immunotherapy, Adoptive*
Research Personnel
United States
United States Food and Drug Administration